US Pharma MarketingThe post Narcolepsy market expected to reach $7.8bn across 7MM by 2035 appeared first on Clinical Trials Arena.
Narcolepsy market expected to reach $7.8bn across 7MM by 2035
With an estimated $4.4bn in drug sales, the US dominated the narcolepsy market in 2025, representing 97% of 7MM sales. With an estimated $4.4bn in drug sales, the US dominated the narcolepsy market in 2025, representing 97% of 7MM sales. While the narcolepsy market is projected to grow during the forecast period across the 7MM, it will face some challenges that will curtail its growth. Credit: fizkes via Shutterstock.com. Unlock FREE Access to Premium Content Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation. With a free Clinical Trials Arena…
With an estimated $4.4bn in drug sales, the US dominated the narcolepsy market in 2025, representing 97% of 7MM sales.
Source: Clinical Trials Arena